We are live on ! Find out more
LPC

Lion Point Capital Portfolio holdings

AUM $20.9M
1-Year Est. Return 195.52%
This Fund
S&P 500
This Quarter Est. Return
+58.26%
1 Year Est. Return
+195.52%
3 Year Est. Return
+318.83%
5 Year Est. Return
+369%
10 Year Est. Return
+2,361.28%
AUM
$20.9M
AUM Growth
+$4.17M
Cap. Flow
-$463K
Cap. Flow %
-2.22%
Top 10 Hldgs %
55.01%
Holding
35
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CUE icon
Cue Biopharma
CUE
+$463K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JANX icon
26
Janux Therapeutics
JANX
$1.24B
$292K 1.4%
19,000
– –
MLYS icon
27
Mineralys Therapeutics
MLYS
$2.49B
$283K 1.36%
10,500
– –
GHRS icon
28
GH Research
GHRS
$1.94B
$274K 1.31%
10,200
– –
MCRB icon
29
Seres Therapeutics
MCRB
$57.5M
$249K 1.19%
31,570
– –
AZTA icon
30
Azenta
AZTA
$1.37B
$248K 1.18%
9,700
– –
JSPR icon
31
Jasper Therapeutics
JSPR
$23.6M
$196K 0.94%
465,000
– –
INVA icon
32
Innoviva
INVA
$1.54B
$186K 0.89%
8,200
– –
IPHA
33
Innate Pharma
IPHA
$232M
$149K 0.71%
81,151
– –
ARQT icon
34
Arcutis Biotherapeutics
ARQT
$3B
$138K 0.66%
5,250
– –
SPRB
35
Spruce Biosciences
SPRB
$166M
$54K 0.26%
1,000
– –
1
2

Similar funds

SCM
Stadium Capital Management New Canaan, Connecticut $21M AUM 6.45% 1-Year Est. Return
MPW
MGO Private Wealth Irvine, California $20.7M AUM 18.57% 1-Year Est. Return
FS
Financially Speaking Greenwood Village, Colorado $20.6M AUM 16.79% 1-Year Est. Return
VAM
Vazirani Asset Management New York $20.3M AUM 79.33% 1-Year Est. Return
SPC
Stone Point Capital Greenwich, Connecticut $21.7M AUM 48.55% 1-Year Est. Return
SCM
Semanteon Capital Management Newton, Massachusetts $22.2M AUM 53.69% 1-Year Est. Return
HIIL
HS Investments III Ltd St. Peter Port $22.3M AUM
PMAM
Penn Mutual Asset Management Conshohocken, Pennsylvania $19.5M AUM 3.07% 1-Year Est. Return

Lion Point Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Lion Point Capital held 35 positions worth $20.9M, up 25% from $16.7M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Lion Point Capital opened no new positions and made no exits, leaving the 35-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Lion Point Capital's biggest Q2 2026 reduction was Cue Biopharma, cutting an estimated $463K.
  • Lion Point Capital's ten largest holdings make up 55% of its $20.9M portfolio in Q2 2026.
  • Lion Point Capital opened 0 new positions and closed 0 in Q2 2026.
  • Lion Point Capital's portfolio value rose 25% quarter-over-quarter to $20.9M.

Based on Lion Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.